Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CODX – Co-Diagnostics, Inc.

Co-Diagnostics, Inc.
CODX
$0.2482
Name : Co-Diagnostics, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $8,367,442.00
EPSttm : -1.17
finviz dynamic chart for CODX
Co-Diagnostics, Inc.
$0.2482
4.02%
$0.0104

Float Short %

2.75

Margin Of Safety %

Put/Call OI Ratio

0.01

EPS Next Q Diff

0.08

EPS Last/This Y

0.56

EPS This/Next Y

0.34

Price

0.25

Target Price

5.5

Analyst Recom

2

Performance Q

-31.98

Relative Volume

1.35

Beta

0.52

Ticker: CODX




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04CODX0.2770.170.002503
2025-07-07CODX0.26730.060.001701
2025-07-08CODX0.28020.060.001701
2025-07-09CODX0.28770.060.001702
2025-07-10CODX0.250.060.011707
2025-07-11CODX0.2470.050.001827
2025-07-14CODX0.26530.010.011690
2025-07-15CODX0.27240.010.001749
2025-07-16CODX0.26330.010.001768
2025-07-17CODX0.27680.010.101795
2025-07-18CODX0.27990.010.001816
2025-07-21CODX0.2810.010.001794
2025-07-22CODX0.2990.010.002022
2025-07-23CODX0.2830.010.092389
2025-07-24CODX0.28410.010.382427
2025-07-25CODX0.280.010.502430
2025-07-28CODX0.2770.010.132413
2025-07-29CODX0.26050.010.002421
2025-07-30CODX0.25510.010.002442
2025-07-31CODX0.25560.010.002443
2025-08-01CODX0.24480.010.002443
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04CODX0.28-2.3- -0.68
2025-07-07CODX0.26-2.3- -0.68
2025-07-08CODX0.28-2.3- -0.68
2025-07-09CODX0.28-2.3- -0.68
2025-07-10CODX0.25-2.3- -0.68
2025-07-11CODX0.25-2.3- -0.68
2025-07-14CODX0.27-2.3- -0.68
2025-07-15CODX0.27-2.3- -0.68
2025-07-16CODX0.26-2.3- -0.68
2025-07-17CODX0.28-2.3- -0.68
2025-07-18CODX0.28-2.3- -0.68
2025-07-21CODX0.28-2.3- -0.68
2025-07-22CODX0.30-2.3- -0.68
2025-07-23CODX0.29-2.3- -0.68
2025-07-24CODX0.28-2.3- -0.68
2025-07-25CODX0.28-2.3- -0.68
2025-07-28CODX0.28-2.3- -0.68
2025-07-29CODX0.26-2.3- -0.68
2025-07-30CODX0.26-2.3- -0.68
2025-07-31CODX0.26-2.3- -0.68
2025-08-01CODX0.25-2.3- -0.68
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04CODX0.002.160.92
2025-07-07CODX0.002.180.92
2025-07-08CODX0.002.180.92
2025-07-09CODX0.002.180.92
2025-07-10CODX0.002.180.92
2025-07-11CODX0.002.180.92
2025-07-14CODX0.002.180.92
2025-07-15CODX0.002.180.92
2025-07-16CODX0.002.180.92
2025-07-17CODX0.002.180.92
2025-07-18CODX0.002.180.92
2025-07-21CODX0.002.180.92
2025-07-22CODX0.002.180.92
2025-07-23CODX0.002.180.92
2025-07-24CODX0.002.180.92
2025-07-25CODX0.002.182.75
2025-07-28CODX0.002.182.75
2025-07-29CODX0.002.182.75
2025-07-30CODX0.002.182.75
2025-07-31CODX0.002.182.75
2025-08-01CODX0.002.182.75
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.24

Avg. EPS Est. Current Quarter

-0.25

Avg. EPS Est. Next Quarter

-0.16

Insider Transactions

Institutional Transactions

2.18

Beta

0.52

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

32

Growth Score

24

Sentiment Score

4

Actual DrawDown %

99.2

Max Drawdown 5-Year %

-99.2

Target Price

5.5

P/E

Forward P/E

PEG

P/S

14.68

P/B

0.17

P/Free Cash Flow

EPS

-1.14

Average EPS Est. Cur. Y​

-0.68

EPS Next Y. (Est.)

-0.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6318.09

Relative Volume

1.35

Return on Equity vs Sector %

-98.6

Return on Equity vs Industry %

-93.1

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.23

EBIT Estimation

Co-Diagnostics, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 132
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
stock quote shares CODX – Co-Diagnostics, Inc. Stock Price stock today
news today CODX – Co-Diagnostics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CODX – Co-Diagnostics, Inc. yahoo finance google finance
stock history CODX – Co-Diagnostics, Inc. invest stock market
stock prices CODX premarket after hours
ticker CODX fair value insiders trading